The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

Uterine manipulation with an intrauterine device is the surgical method used for early-stage cervical cancer. In this study, ...

Scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and Harvard and Columbia University have ...

Netflix's miniseries Apple Cider Vinegar details the "true-ish" story of Belle Gibson, the Australian influencer who really ...

Discover why Black women face higher risks of developing uterine fibroids, as research reveals complex factors from genetics ...

Discover why African American women are disproportionately affected by uterine fibroids and learn about revolutionary treatment options that are changing lives.

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant trial results.

"The lack of a significant link between AmygA and LN metastasis in premenopausal women suggests that menopausal status may ...

The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...

The majority of women with uterine fibroids are asymptomatic, consequently get less clinical attention and fibroid tumors often remain undiagnosed. [23,24] Symptomatic women typically complain ...

The European Commission approves GSK's Jemperli plus chemotherapy to treat all adult patients with primary, advanced or recurrent endometrial cancer.